The commercial macrolide antibiotic fidaxomicin was synthesized in a highly convergent manner. Salient features of this synthesis include a β-selective noviosylation, a β-selective rhamnosylation, a ring-closing metathesis, a Suzuki coupling, and a vinylogous Mukaiyama aldol reaction. Careful choice of protecting groups and fine-tuning of the glycosylation reactions led to the first total synthesis of fidaxomicin. In addition, a relay synthesis of fidaxomicin was established, which gives access to a conveniently protected intermediate from the natural material for derivatization. The first total synthesis of a related congener, tiacumicin A, is presented
Tiacumicin B (<b>1</b>, also known as fidaxomicin or difimicin) is a marketed drug for the treatment...
International audienceAn enantioselective synthesis of a putative lipiarmycin aglycon was accomplish...
Tiacumicin B (1, also known as fidaxomicin or difimicin) is a marketed drug for the treatment of Clo...
The commercial macrolide antibiotic fidaxomicin was synthesized in a highly convergent manner. Salie...
The commercial macrolide antibiotic fidaxomicin was synthesized in a highly convergent manner. Salie...
Fidaxomicin, also known as tiacumicin B or lipiarmycin A3, is a novel macrocyclic antibiotic that is...
The first enantioselective total synthesis of fidaxomicin, also known as tiacumicin B or lipiarmycin...
Fidaxomicin (1, lipiarmycin A3, clostomicin B1, tiacumicin B) constitutes a glycosylated 18-membered...
The first enantioselective total synthesis of fidaxomicin, also known as tiacumicin B or lipiarmycin...
Fidaxomicin (1, tiacumicin B, lipiarmycin A3) is a marketed antibiotic that is used in the treatment...
The glycoslated macrocyclic antibiotic fidaxomicin (1, tiacumicin B, lipiarmycin A3) displays good t...
The glycoslated macrocyclic antibiotic fidaxomicin (1, tiacumicin B, lipiarmycin A3) displays good t...
The natural product antibiotic fidaxomicin is a marketed drug for the treatment of bacterial infecti...
This thesis is divided into two chapters, describing two organic chemistry projects, both born from ...
Fidaxomicin (FDX) is a marketed antibiotic for the treatment of Clostridioides difficile infections ...
Tiacumicin B (<b>1</b>, also known as fidaxomicin or difimicin) is a marketed drug for the treatment...
International audienceAn enantioselective synthesis of a putative lipiarmycin aglycon was accomplish...
Tiacumicin B (1, also known as fidaxomicin or difimicin) is a marketed drug for the treatment of Clo...
The commercial macrolide antibiotic fidaxomicin was synthesized in a highly convergent manner. Salie...
The commercial macrolide antibiotic fidaxomicin was synthesized in a highly convergent manner. Salie...
Fidaxomicin, also known as tiacumicin B or lipiarmycin A3, is a novel macrocyclic antibiotic that is...
The first enantioselective total synthesis of fidaxomicin, also known as tiacumicin B or lipiarmycin...
Fidaxomicin (1, lipiarmycin A3, clostomicin B1, tiacumicin B) constitutes a glycosylated 18-membered...
The first enantioselective total synthesis of fidaxomicin, also known as tiacumicin B or lipiarmycin...
Fidaxomicin (1, tiacumicin B, lipiarmycin A3) is a marketed antibiotic that is used in the treatment...
The glycoslated macrocyclic antibiotic fidaxomicin (1, tiacumicin B, lipiarmycin A3) displays good t...
The glycoslated macrocyclic antibiotic fidaxomicin (1, tiacumicin B, lipiarmycin A3) displays good t...
The natural product antibiotic fidaxomicin is a marketed drug for the treatment of bacterial infecti...
This thesis is divided into two chapters, describing two organic chemistry projects, both born from ...
Fidaxomicin (FDX) is a marketed antibiotic for the treatment of Clostridioides difficile infections ...
Tiacumicin B (<b>1</b>, also known as fidaxomicin or difimicin) is a marketed drug for the treatment...
International audienceAn enantioselective synthesis of a putative lipiarmycin aglycon was accomplish...
Tiacumicin B (1, also known as fidaxomicin or difimicin) is a marketed drug for the treatment of Clo...